Clinical Trial

Assessing Systemic Treatment and ctDNA Monitoring Efficacy in Metastatic Cancer Patients Using K4Care Testing.

Study acronym: GS_ZKM
Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this observational study is to investigate the real-world treatment landscape of patients with metastatic cancer and determine the role of ctDNA in monitoring treatment response in patients with metastatic cancer who have undergone K4Care testing
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-04-08; most recent amendment 2025-07-12.
Status change: Not Yet Recruiting → Recruiting 2025-07-12
Trial Details
NCT Number NCT06929910
Lead Sponsor Gene Solutions
Collaborators: The Medical Genetics Institute (MGI) of HCMC
Conditions Metastatic Cancers
Enrollment 200 participants
Start Date 2025-04-09
Primary Completion 2026-12-31 (estimated)
Study Completion 2027-06-30 (estimated)
Updated on ClinicalTrials.gov 2025-07-16